Ibio Common Stock Stock Technical Analysis

IBIO Stock  USD 2.21  0.06  2.64%   
As of the 12th of February 2026, IBio Common retains the Market Risk Adjusted Performance of 0.9178, downside deviation of 6.77, and Semi Deviation of 6.17. IBio Common technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices.

IBio Common Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as IBio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IBioIBio Common's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

IBio Common Analyst Consensus

Target PriceConsensus# of Analysts
4.4Strong Buy3Odds
iBio Common Stock current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most IBio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand IBio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of iBio Common Stock, talking to its executives and customers, or listening to IBio conference calls.
IBio Analyst Advice Details
Will Biotechnology sector continue expanding? Could IBio diversify its offerings? Factors like these will boost the valuation of IBio Common. Market participants price IBio higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every IBio Common data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(1.40)
Revenue Per Share
0.038
Quarterly Revenue Growth
0.143
Return On Assets
(0.29)
Return On Equity
(0.55)
iBio Common Stock's market price often diverges from its book value, the accounting figure shown on IBio's balance sheet. Smart investors calculate IBio Common's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since IBio Common's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IBio Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if IBio Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IBio Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

IBio Common 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IBio Common's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IBio Common.
0.00
11/14/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/12/2026
0.00
If you would invest  0.00  in IBio Common on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding iBio Common Stock or generate 0.0% return on investment in IBio Common over 90 days. IBio Common is related to or competes with Iterum Therapeutics, Pluri, Intensity Therapeutics, Rallybio Corp, Exicure, Klotho Neurosciences, and AN2 Therapeutics. iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third... More

IBio Common Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IBio Common's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess iBio Common Stock upside and downside potential and time the market with a certain degree of confidence.

IBio Common Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for IBio Common's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IBio Common's standard deviation. In reality, there are many statistical measures that can use IBio Common historical prices to predict the future IBio Common's volatility.
Hype
Prediction
LowEstimatedHigh
0.101.9612.39
Details
Intrinsic
Valuation
LowRealHigh
0.132.6313.06
Details
3 Analysts
Consensus
LowTargetHigh
4.004.404.88
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.07-0.07-0.06
Details

IBio Common February 12, 2026 Technical Indicators

iBio Common Stock Backtested Returns

IBio Common is dangerous given 3 months investment horizon. iBio Common Stock holds Efficiency (Sharpe) Ratio of 0.15, which attests that the company had a 0.15 % return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.58% are justified by taking the suggested risk. Use iBio Common Stock Downside Deviation of 6.77, market risk adjusted performance of 0.9178, and Semi Deviation of 6.17 to evaluate company specific risk that cannot be diversified away. IBio Common holds a performance score of 11 on a scale of zero to a hundred. The firm retains a Market Volatility (i.e., Beta) of 1.28, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, IBio Common will likely underperform. Use iBio Common Stock downside variance, and the relationship between the sortino ratio and accumulation distribution , to analyze future returns on iBio Common Stock.

Auto-correlation

    
  0.12  

Insignificant predictability

iBio Common Stock has insignificant predictability. Overlapping area represents the amount of predictability between IBio Common time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of iBio Common Stock price movement. The serial correlation of 0.12 indicates that less than 12.0% of current IBio Common price fluctuation can be explain by its past prices.
Correlation Coefficient0.12
Spearman Rank Test0.35
Residual Average0.0
Price Variance0.05
IBio Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of IBio Common technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of IBio Common trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

iBio Common Stock Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for iBio Common Stock across different markets.

About IBio Common Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of iBio Common Stock on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of iBio Common Stock based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on iBio Common Stock price pattern first instead of the macroeconomic environment surrounding iBio Common Stock. By analyzing IBio Common's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of IBio Common's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to IBio Common specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2020 2021 2025 2026 (projected)
Payables Turnover0.650.891.021.22
Days Of Inventory On Hand6.74375.49431.82422.46

IBio Common February 12, 2026 Technical Indicators

Most technical analysis of IBio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for IBio from various momentum indicators to cycle indicators. When you analyze IBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

IBio Common February 12, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as IBio stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether iBio Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IBio Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ibio Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ibio Common Stock Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iBio Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Will Biotechnology sector continue expanding? Could IBio diversify its offerings? Factors like these will boost the valuation of IBio Common. Market participants price IBio higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every IBio Common data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(1.40)
Revenue Per Share
0.038
Quarterly Revenue Growth
0.143
Return On Assets
(0.29)
Return On Equity
(0.55)
iBio Common Stock's market price often diverges from its book value, the accounting figure shown on IBio's balance sheet. Smart investors calculate IBio Common's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since IBio Common's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IBio Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if IBio Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IBio Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.